Differential Diagnosis for Abdominal Pain: Small Bowel Obstruction, Acute Mesenteric Ischaemia, Diverticulitis, Pyelonephritis, and Viral Gastroenteritis

Abdominal pain can have various causes, and it is important to consider different possibilities to provide appropriate management. Here are some differential diagnoses for abdominal pain:

Small bowel obstruction (SBO) is characterized by vomiting, lack of bowel movements, and hyperactive bowel sounds. Patients who have had radiation therapy to their abdomen are at risk for SBO. Urgent management includes abdominal plain film, intravenous fluids, nasogastric tube placement, analgesia, and surgical review.

Acute mesenteric ischaemia is caused by reduced arterial blood flow to the small intestine. Patients with vascular risk factors such as hypertension, smoking, and diabetes mellitus are at risk. Acute-onset abdominal pain that is out of proportion to examination findings is a common symptom.

Diverticulitis presents with left iliac fossa pain, pyrexia, and leukocytosis. Vital signs are usually stable.

Pyelonephritis is characterized by fevers or chills, flank pain, and lower urinary tract symptoms.

Viral gastroenteritis typically presents with fast-onset diarrhea and vomiting after ingestion of contaminated food. However, the patient in this case has not had bowel movements for four days.

In summary, abdominal pain can have various causes, and it is important to consider the patient’s history, physical examination, and laboratory findings to arrive at an accurate diagnosis and provide appropriate management.

Venesection is the primary treatment for haemochromatosis, with a target serum ferritin of less than 50 mcg/L achieved within three to six months. Azathioprine and prednisolone are not used in treatment, while iron chelators such as desferrioxamine are reserved for certain cases. Ursodeoxycholic acid is used in treating primary biliary cirrhosis.

Treatment Options for Hepatitis C: Direct Acting Antivirals and Combination Therapies

Hepatitis C is a viral infection that can lead to serious long-term health complications such as cirrhosis and liver cancer. Interferon-based treatments are no longer recommended as first-line therapy for hepatitis C, as direct acting antivirals (DAAs) have proven to be more effective. DAAs target different stages of the hepatitis C virus lifecycle and have a success rate of over 90%. Treatment typically involves a once-daily oral tablet regimen for 8-12 weeks and is most effective when given before cirrhosis develops.

While ribavirin alone is not as effective, combination therapies such as PEG-interferon α and ribavirin have been used in the past. However, for patients with genotype 1 disease (which has a worse prognosis), the addition of a protease inhibitor to the treatment regimen is recommended for better outcomes.

It is important to note that blood-borne infection rates for hepatitis C are high and can occur after just one or two instances of sharing needles during recreational drug use. Testing for hepatitis C involves antibody testing, followed by RNA and genotyping to guide the appropriate combination and length of treatment.

Overall, the combination of PEG-interferon, ribavirin, and a protease inhibitor is no longer used in the treatment of hepatitis C, as newer and more effective therapies have been developed.

H. pylori infection is a common cause of peptic ulceration and increases the risk of gastric adenocarcinoma. A PPI-based triple therapy is effective in 90% of cases with low rates of re-infection. For patients not allergic to penicillin, a 7-day PPI triple therapy including omeprazole, clarithromycin, and amoxicillin is appropriate. Metronidazole is given twice daily for seven days, while levofloxacin is only used if the patient has had previous exposure to clarithromycin. Quadruple therapy, including metronidazole or clarithromycin, bismuth, tetracycline, and PPI, is second-line in H. pylori eradication and is given for two weeks. In penicillin-allergic patients, clarithromycin and metronidazole are used with a PPI.

Treatment Options for Small Intestinal Bacterial Overgrowth (SIBO)

Small intestinal bacterial overgrowth (SIBO) is a condition that can cause malabsorption, chronic diarrhea, and megaloblastic anemia. It is often caused by a failure of normal mechanisms that control bacterial growth within the small gut, such as decreased gastric acid secretion and factors that affect gut motility. Patients who have had intestinal surgery are also at an increased risk of developing SIBO.

The most effective treatment for SIBO is a course of antibiotics, such as metronidazole, ciprofloxacin, co-amoxiclav, or rifaximin. A 2-week course of antibiotics may be tried initially, but in many patients, long-term antibiotic therapy may be needed.

In contrast, a gluten-free diet is the treatment for coeliac disease, which presents with malabsorption and iron deficiency anemia. Steroids are not an appropriate treatment for SIBO or coeliac disease, as they can suppress local immunity and allow further bacterial overgrowth.

Vitamin B12 replacement is necessary for patients with SIBO who have megaloblastic anemia due to B12 malabsorption and metabolism by bacteria. There is no indication of intestinal tuberculosis in this patient, but in suspected cases, intestinal biopsy may be needed.

Management of Suspected Oesophageal Rupture

Suspected oesophageal rupture is a medical emergency that requires urgent intervention. This condition is more common in patients with a history of alcohol excess and can be associated with a triad of vomiting, chest pain, and subcutaneous emphysema. Symptoms include retrosternal chest/epigastric pain, tachypnoea, fever, pain on swallowing, and shock. A chest X-ray reveals gas within soft tissue spaces, pneumomediastinum, left pleural effusion, and left-sided pneumothorax. Without rapid treatment, the condition can be fatal.

Antibiotics are necessary to treat the infection that may result from oesophageal rupture. However, they will not address the underlying cause of the infection.

Chest drain insertion is not the correct management for pneumothorax secondary to oesophageal rupture. A chest drain would not resolve the underlying cause, and air would continue to enter the pleural cavity via the oesophagus.

Proton pump inhibitors (PPIs) are not appropriate for suspected oesophageal rupture. PPIs would be the correct management for a suspected perforated ulcer. However, the history of acute-onset pain following vomiting is more in keeping with oesophageal rupture.

Urgent endoscopy is not appropriate for suspected oesophageal rupture. Endoscopy risks further oesophageal perforation, and there is no report of haematemesis or melaena, making this a less likely cause of the patient’s symptoms.

Management of Suspected Oesophageal Rupture: Antibiotics, Chest Drain Insertion, PPIs, and Endoscopy

The Importance of Endoscopy in Diagnosing and Treating Upper GI Bleeds

When a patient presents with an upper GI bleed, it is important to determine the cause and provide appropriate treatment. In cases where the bleed is likely caused by a duodenal ulcer from non-steroidal anti-inflammatory drug use, an OGD (oesophago-gastro-duodenoscopy) is necessary for diagnosis and initial therapeutic management. Endoscopy allows for the identification of a bleeding ulcer, which can then be injected with adrenaline and clipped to prevent re-bleeding.

Continued transfusion may help resuscitate the patient, but it will not stop the bleeding. A CT scan with embolisation could be useful, but a CT scan alone would not be sufficient. Laparotomy should only be considered if endoscopic therapy fails. Diagnostic laparoscopy is not necessary as a clinical diagnosis can be made based on the patient’s history and condition.

In conclusion, endoscopy is crucial in diagnosing and treating upper GI bleeds, particularly in cases where a duodenal ulcer is suspected. It allows for immediate intervention to stop the bleeding and prevent further complications.

Markers for Severity and Mortality in Pancreatitis

Pancreatitis is a serious condition that requires prompt diagnosis and management. Several markers can help assess the severity of the disease and predict mortality. The modified Glasgow severity score is a useful tool for stratifying patients based on their clinical presentation. A score of 3 or above indicates severe pancreatitis and the need for transfer to the Intensive Therapy Unit.

Serum amylase is a diagnostic marker for pancreatitis, but its levels may be normal even in severe cases. Elevated amylase levels can also occur in other acute conditions, such as acute cholecystitis or intestinal obstruction. Therefore, it should not be used as a serial marker for assessing disease progression. Instead, serial C-reactive protein levels are more useful for this purpose.

Serum albumin is an important marker of mortality in pancreatitis. A fall in albumin level can contribute to peripheral edema and difficulty in maintaining blood pressure. Age is another predictor of mortality, as it is associated with co-morbidities. Corrected calcium is a useful marker for severe pancreatitis, as it indicates the precipitation of calcium in the abdomen, causing hypocalcemia. Finally, white cell count is a marker of inflammation and can indicate the spread of the disease.

In conclusion, a combination of these markers can help clinicians assess the severity of pancreatitis and predict mortality. Early recognition and management of severe cases can improve outcomes and reduce morbidity and mortality.

Diagnosis and Treatment of Giardiasis in Traveller’s Diarrhoea

Traveller’s diarrhoea is a common condition that can occur when travelling to different parts of the world. In this case, the patient is likely suffering from giardiasis, which is caused by a parasite that can be found in contaminated water or food. The best way to diagnose giardiasis is through microscopic examination of the faeces, where cysts may be seen. However, in some cases, chronic disease may occur, and cysts may not be found in the faeces. In such cases, a duodenal aspirate or biopsy may be required to confirm the diagnosis.

The treatment for giardiasis is metronidazole, which is an antibiotic that is effective against the parasite.

According to NICE guidelines, women over the age of 50 who experience regular symptoms such as abdominal bloating, loss of appetite, pelvic or abdominal pain, and increased urinary urgency and/or frequency should undergo serum CA125 testing. It is important to note that irritable bowel disease rarely presents for the first time in women over 50, so any symptoms suggestive of IBD should prompt appropriate tests for ovarian cancer. If serum CA125 levels are elevated, an ultrasound of the abdomen and pelvis should be arranged. If malignancy is suspected, urgent referral must be made. Physical examination may also warrant direct referral to gynaecology if ascites and/or a suspicious abdominal or pelvic mass is identified.

Ovarian cancer is a common malignancy in women, ranking fifth in frequency. It is most commonly diagnosed in women over the age of 60 and has a poor prognosis due to late detection. The majority of ovarian cancers, around 90%, are of epithelial origin, with serous carcinomas accounting for 70-80% of cases. Interestingly, recent research suggests that many ovarian cancers may actually originate in the distal end of the fallopian tube. Risk factors for ovarian cancer include a family history of BRCA1 or BRCA2 gene mutations, early menarche, late menopause, and nulliparity.

Clinical features of ovarian cancer are often vague and can include abdominal distension and bloating, abdominal and pelvic pain, urinary symptoms such as urgency, early satiety, and diarrhea. The initial diagnostic test recommended by NICE is a CA125 blood test, although this can also be elevated in other conditions such as endometriosis and benign ovarian cysts. If the CA125 level is raised, an urgent ultrasound scan of the abdomen and pelvis should be ordered. However, a CA125 test should not be used for screening asymptomatic women. Diagnosis of ovarian cancer is difficult and usually requires a diagnostic laparotomy.

Management of ovarian cancer typically involves a combination of surgery and platinum-based chemotherapy. Unfortunately, 80% of women have advanced disease at the time of diagnosis, leading to a 5-year survival rate of only 46%. It was previously thought that infertility treatment increased the risk of ovarian cancer due to increased ovulation, but recent evidence suggests that this is not a significant factor. In fact, the combined oral contraceptive pill and multiple pregnancies have been shown to reduce the risk of ovarian cancer by reducing the number of ovulations.

Management of Gastroenteritis in Children

Gastroenteritis is a common illness in children that is usually caused by a viral infection. Antibiotics are not necessary in most cases as they are only effective against bacterial infections. Changing formula feeds is also not recommended as it may cause further digestive problems. However, if the child is unable to tolerate oral fluids, intravenous fluid therapy may be necessary to prevent dehydration.

Lactose intolerance is a common occurrence in children with gastroenteritis, but it is not inevitable. It is important to monitor the child’s symptoms and adjust their diet accordingly. Barium meals are not useful in the investigation of gastroenteritis as they are more commonly used to diagnose structural abnormalities in the digestive system.

In summary, the management of gastroenteritis in children involves providing supportive care such as oral rehydration therapy and monitoring for signs of dehydration. Antibiotics are not necessary unless there is a bacterial infection present. It is important to be aware of the possibility of lactose intolerance and adjust the child’s diet accordingly. Barium meals are not useful in the investigation of gastroenteritis.

Arteries that supply the stomach: A brief overview

The stomach is a vital organ that requires a constant supply of blood to function properly. There are several arteries that supply blood to different parts of the stomach. Here is a brief overview of these arteries:

1. Left gastric artery: This artery supplies the lesser curvature of the stomach along with the right gastric artery. Bleeding at the lesser curvature of the stomach is most likely to be caused by these two arteries. The left gastric artery is one of the three branches that arise from the coeliac trunk.

2. Right gastroepiploic artery: This artery, along with the left gastroepiploic artery, supplies the greater curvature of the stomach.

3. Left gastroepiploic artery: This artery, along with the right gastroepiploic artery, supplies the greater curvature of the stomach.

4. Gastroduodenal artery: This artery is a branch off the common hepatic artery that supplies the duodenum, head of the pancreas, and greater curvature of the stomach.

5. Short gastric arteries: These are four or five small arteries from the splenic artery that supply the fundus of the stomach.

Understanding the different arteries that supply the stomach is important for diagnosing and treating various medical conditions related to the stomach.

Anatomy of the Stomach: Regions and Parts

The stomach is a muscular organ located in the upper abdomen that plays a crucial role in digestion. It is divided into several regions and parts, each with its own unique function. Here is a breakdown of the anatomy of the stomach:

Cardia: This region surrounds the opening of the oesophagus into the stomach and is adjacent to the fundus. It is in continuity with the body of the stomach.

Fundus: The fundus is the uppermost region of the stomach that is in contact with the inferior surface of the diaphragm. It is located above the level of the cardial orifice.

Body: The body is the largest region of the stomach and is located between the fundus and pyloric antrum. It has a greater and lesser curvature.

Pyloric antrum: This region is the proximal part of the pylorus, which is the distal part of the stomach. It lies between the body of the stomach and the first part of the duodenum.

Pyloric canal: The pyloric canal is the distal part of the pylorus that leads to the muscular pyloric sphincter.

Understanding the different regions and parts of the stomach is important for diagnosing and treating various digestive disorders.

Differential diagnosis of jaundice: considering cholangiocarcinoma, malaria, haemolytic anaemia, acute cholecystitis, and pancreatitis

Jaundice is a common clinical manifestation of various diseases, including liver, biliary, and haematological disorders. When evaluating a patient with jaundice, it is important to consider the differential diagnosis based on the clinical features and risk factors. One rare but important cause of jaundice is cholangiocarcinoma, a cancer of the bile ducts that typically presents with painless progressive jaundice, hepatomegaly, and risk factors such as male gender, age over 50, and certain liver diseases. However, other conditions such as malaria and haemolytic anaemia can also cause pre-hepatic jaundice, which is characterized by elevated bilirubin levels but normal urine and stool colours. Acute cholecystitis, on the other hand, typically presents with severe abdominal pain, fever, and signs of inflammation, while pancreatitis is characterized by epigastric pain, fever, and elevated pancreatic enzymes. Therefore, a thorough history, physical examination, and laboratory tests are necessary to differentiate these conditions and guide appropriate management.

Management of Aphthous Ulcers: Topical Steroids and Pain Control

Aphthous ulcers are a common benign oral lesion that can be triggered by local trauma or certain foods. The first-line management for this condition typically involves topical steroids and topical lidocaine for pain control. Biopsy of the lesion is not indicated unless the ulcer is not healing after three weeks and malignancy needs to be excluded. Epstein-Barr virus testing is only necessary if there are signs of oral hairy leucoplakia. Immediate specialist referral is necessary if there are signs of malignancy. Oral steroids can be considered in refractory cases, but should be used cautiously in patients with diabetes mellitus.

Likely Causes of Hepatitis in a Patient: A Differential Diagnosis

Upon considering the patient’s medical history, it is highly likely that the cause of their illness is hepatitis A. This is due to the patient’s recent travel history and lack of risk factors for other types of hepatitis. Hepatitis A is highly infectious and is transmitted through the faeco-oral route, often through contaminated water or poor sanitation.

Hepatitis C and B are less likely causes as the patient denies any risk factors for these types of hepatitis, such as blood transfusions, unprotected sexual intercourse, or IV drug use. Hepatitis D is also unlikely as it is co-transmitted with hepatitis B.

Yellow fever is a possibility, but the patient has not traveled to any endemic areas, such as tropical rainforests, making it less likely.

In conclusion, based on the patient’s medical history and lack of risk factors, hepatitis A is the most likely cause of their illness.

Serologic Markers of Autoimmune Diseases

There are several serologic markers used to diagnose autoimmune diseases. These markers include perinuclear antineutrophil cytoplasmic antibodies (p-ANCA), anti-dsDNA antibody, antinuclear antibodies (ANA), anti-smooth muscle antibody (ASMA), and anti-Saccharomyces cerevisiae antibody (ASCA).

p-ANCA is elevated in patients with ulcerative colitis and/or primary sclerosing cholangitis (PSC). Anti-dsDNA antibody is found in systemic lupus erythematosus (SLE). ANA is a sensitive, but not specific, marker for a variety of autoimmune diseases such as SLE, mixed connective tissue disorder (MCTD), and rheumatoid arthritis (RA). ASMA, ANA, and anti-liver–kidney microsomal antibody-1 (LKM-1) are serologic markers of autoimmune hepatitis. Increased levels of ASCA are often associated with Crohn’s disease.

These serologic markers are useful in diagnosing autoimmune diseases, but they are not always specific to a particular disease. Therefore, they should be used in conjunction with other diagnostic tests and clinical evaluation.

Understanding Achalasia: Causes, Symptoms, Diagnosis, and Treatment

Achalasia is a condition where the lower esophageal sphincter fails to relax, causing difficulty in swallowing and regurgitation of undigested food. This is commonly due to the denervation of inhibitory neurons in the distal esophagus, leading to a progressive worsening of symptoms over time. Diagnosis is made through a barium study and manometry, which reveal a bird’s beak appearance of the lower esophagus and an abnormally high sphincter tone that fails to relax on swallowing. Nitric oxide, which increases smooth muscle relaxation and reduces sphincter tone, is reduced in achalasia. Treatment options include surgical intervention, botulinum toxin injection, and pharmacotherapy with drugs such as calcium channel blockers, long-acting nitrates, and sildenafil.

Other gastrointestinal hormones such as cholecystokinin, motilin, somatostatin, and gastrin do not play a role in achalasia. Cholecystokinin stimulates pancreatic secretion and gallbladder contractions, while motilin is responsible for migrating motor complexes. Somatostatin decreases gastric acid and pancreatic secretion and gallbladder contractions. Gastrin promotes hydrochloric acid secretion in the stomach and can result in Zollinger-Ellison syndrome when produced in excess by a gastrinoma.

The patient in this scenario presents with symptoms that suggest a blockage in their bowel and potential signs of cancer, such as a loss of appetite and anemia. Therefore, the most important initial investigation is a colonoscopy. A colonic transit study is not appropriate as it is used for slow colonic transit and this patient has symptoms of obstruction. An abdominal X-ray can be used to investigate faecal impaction and rectal masses, but a colonoscopy should be used first-line for detailed information about colonic masses. While a CT abdomen may be needed, a colonoscopy should be performed as the initial investigation for intestinal luminal obstruction and potential malignancy. Checking thyroid function may be useful if there is suspicion of a secondary cause of constipation, but in this case, the patient’s symptoms suggest colonic obstruction and cancer, making a thyroid function test an inappropriate initial investigation.

Differences between Ulcerative Colitis and Crohn’s Colitis

Ulcerative colitis (UC) and Crohn’s colitis are two types of inflammatory bowel disease (IBD) that affect the colon and rectum. However, there are several differences between the two conditions.

Rectal Involvement
UC usually originates in the rectum and progresses proximally, while Crohn’s colitis can affect any part of the gastrointestinal tract, including the duodenum.

Transmural Inflammation
Crohn’s colitis involves transmural inflammation, while UC typically affects only the submucosa or mucosa.

Anal Fistulae and Abscesses
Crohn’s colitis is more likely to cause anal fistulae and abscesses due to its transmural inflammation, while UC is less prone to these complications.

Duodenal Involvement
UC usually affects only the colon, while Crohn’s colitis can involve the duodenum. As a result, colectomy is often curative in UC but not in Crohn’s disease.

Symptoms and Severity
Both conditions can cause bloody diarrhea, weight loss, and abdominal pain. However, the severity of UC is measured by the number of bowel movements per day, abdominal pain and distension, signs of toxicity, blood loss and anemia, and colon dilation.

Understanding the Differences between Ulcerative Colitis and Crohn’s Colitis

Infantile Hypertrophic Pyloric Stenosis

Infantile hypertrophic pyloric stenosis is a condition that is most commonly observed in first-born male children. One of the most characteristic symptoms of this condition is projectile vomiting of large quantities of curdled milk. However, anorexia and loose stools are not typically observed in patients with this condition. The biochemical picture of infantile hypertrophic pyloric stenosis is typically hypokalaemic, hypochloraemic metabolic alkalosis.

This condition is caused by hypertrophy and hyperplasia of the pyloric sphincter, which leads to obstruction of the gastric outlet. This obstruction can cause the stomach to become distended, leading to vomiting. Diagnosis of infantile hypertrophic pyloric stenosis is typically made through ultrasound imaging, which can reveal the thickened pyloric muscle. Treatment for this condition typically involves surgical intervention to relieve the obstruction and allow for normal gastric emptying.

Appropriate Treatment for Pancreatitis and Cholecystitis: Differentiating Symptoms and Initial Management

Pancreatitis and cholecystitis are two conditions that can present with similar symptoms, such as epigastric pain and nausea. However, the nature of the pain and other clinical indicators can help differentiate between the two and guide appropriate initial treatment.

For a patient with pancreatitis, initial treatment would involve admission, IV fluids, analgesia, and keeping them nil by mouth. A nasogastric tube may also be placed to help with vomiting and facilitate healing. Antibiotics and surgical intervention are not typically indicated unless there are complications such as necrosis or abscess.

In contrast, a patient with cholecystitis would receive broad-spectrum antibiotics and analgesia as initial management. Laparoscopic cholecystectomy would only be considered after further investigations such as abdominal ultrasound or MRCP.

It’s important to note that other factors, such as a recent history of travel, may also need to be considered in determining appropriate treatment. However, careful evaluation of symptoms and clinical indicators can help guide initial management and ensure the best possible outcomes for patients.

Treatment Options for Gastrinoma: Octreotide, Somatostatin Antagonist, Bromocriptine, Pergolide, and Leuprolide

Gastrinoma is a rare condition characterized by multiple, recurrent, and refractory peptic ulcer disease, along with watery diarrhea and weight loss. The diagnosis is supported by an elevated serum gastrin level that is not suppressed by the test meal. While neoplastic masses of gastrinoma may or may not be localized by abdominal imaging, treatment options are available.

Octreotide, a synthetic somatostatin, is useful in the treatment of gastrinoma, acromegaly, carcinoid tumor, and glucagonoma. Somatostatin is an inhibitory hormone in several endocrine systems, and a somatostatin antagonist would increase gastrin, growth hormone, and glucagon secretion. However, it has no role in the treatment of gastrinoma.

Bromocriptine, a dopamine agonist, is used in the treatment of Parkinson’s disease, hyperprolactinemia, and pituitary tumors. Pergolide, another dopamine receptor agonist, was formerly used in the treatment of Parkinson’s disease but is no longer administered due to its association with valvular heart disease. Neither medication has a role in the treatment of gastrinoma.

Leuprolide, a gonadotropin-releasing hormone (GnRH) receptor agonist, is used in the treatment of sex hormone-sensitive tumors such as prostate or breast cancer. It also has no role in the treatment of gastrinoma. Overall, octreotide remains the primary treatment option for gastrinoma.

Understanding Achalasia: Symptoms, Diagnosis, and Differential Diagnosis

Achalasia is a motility disorder that affects the lower esophageal sphincter, causing difficulty swallowing both liquids and solids. This condition is characterized by the failure of the sphincter to relax in response to peristalsis during swallowing, which can lead to chest pain after eating and regurgitation of food. The cause of achalasia is unknown, but it is thought to be due to degeneration of the myenteric plexus.

To diagnose achalasia, a barium swallow may reveal a dilated esophagus with a bird’s beak tapering of the distal esophagus. Manometry can confirm the high-pressure, non-relaxing lower esophageal sphincter. Endoscopy should also be carried out to exclude malignancy.

Differential diagnosis for achalasia includes oesophageal carcinoma, pharyngeal pouch, benign oesophageal stricture, and caustic stricture. Oesophageal carcinoma is less likely in a relatively young patient without history of weight loss, and the barium swallow findings are more suggestive of achalasia than malignancy. A pharyngeal pouch would be visualized on a barium swallow, while a benign oesophageal stricture is more common in older people with a history of gastro-oesophageal reflux disease. Caustic stricture would also be visualized on a barium swallow, but there is no history of caustic damage in this case.

Causes of Acute Diarrhoea and Haemolytic Uraemic Syndrome

Enterohaemorrhagic verocytotoxin-producing E coli 0157:H7 is the most probable cause of acute diarrhoea and haemolytic uraemic syndrome. This type of E coli is known to produce toxins that can damage the lining of the intestine and cause bloody diarrhoea. In severe cases, it can lead to haemolytic uraemic syndrome, a condition that affects the kidneys and can cause kidney failure.

Crohn’s disease is an inflammatory bowel disease that can cause chronic diarrhoea, but it would be unusual for it to present acutely as in this case. Polio and giardiasis are other possible causes of diarrhoea, but they typically present as non-bloody diarrhoea. It is important to identify the underlying cause of acute diarrhoea and haemolytic uraemic syndrome to provide appropriate treatment and prevent complications.

Anatomical Landmarks and their Surface Markings in the Abdomen

The human abdomen is a complex region with various structures and organs that are important for digestion and metabolism. In this article, we will discuss some of the anatomical landmarks and their surface markings in the abdomen.

Surface Marking: Lateral edge of right rectus abdominis muscle and the costal margin
Anatomical Landmark: Fundus of the gallbladder

The fundus of the gallbladder is located closest to the anterior abdominal wall. Its surface marking is the point where the lateral edge of the right rectus abdominis muscle meets the costal margin, which is also in the transpyloric plane. It is important to note that Courvoisier’s law exists in surgery, which states that a palpable, enlarged gallbladder accompanied by painless jaundice is unlikely to be caused by gallstone disease.

Surface Marking: Anterior axillary line and the transpyloric plane
Anatomical Landmark: Hilum of the spleen

The transpyloric plane is an imaginary line that runs axially approximately at the L1 vertebral body. The hilum of the spleen can be found at the intersection of the anterior axillary line and the transpyloric plane.

Surface Marking: Linea alba and the transpyloric plane
Anatomical Landmark: Origin of the superior mesenteric artery

The origin of the superior mesenteric artery can be found at the intersection of the linea alba and the transpyloric plane.

Surface Marking: Mid-clavicular line and the transpyloric plane
Anatomical Landmark: Hepatic flexure of the colon on the right and splenic flexure of the colon on the left

At the intersection of the mid-clavicular line and the transpyloric plane, the hepatic flexure of the colon can be found on the right and the splenic flexure of the colon on the left.

Surface Marking: Mid-clavicular line and a horizontal line through the umbilicus
Anatomical Landmark: Ascending colon on the right and descending colon on the left

At the intersection of the mid-clavicular line and a horizontal line through the umbilicus, the ascending colon is found on the right and the descending colon on the left. If the liver or spleen are enlarged, their tips can also

Haemochromatosis is a genetic disorder that causes the body to absorb too much iron, leading to iron overload and deposition in vital organs such as the liver and pancreas. It is inherited in an autosomal recessive manner, with a frequency of homozygotes in the population of 1:500. The disorder is most commonly found in Celtic nations. Symptoms typically present in the third to fourth decade of life in men and post-menopause in women and include weakness, fatigue, skin bronzing, diabetes, cirrhosis, and cardiac disease. Treatment involves venesection, and in severe cases, liver transplantation may be necessary. Haemochromatosis increases the risk of developing liver cirrhosis and hepatocellular carcinoma by up to 200-fold. Iron deposition in the pancreas can also lead to diabetes, and patients with haemochromatosis who develop diabetes usually require insulin treatment. Arthropathy associated with haemochromatosis is the result of pseudogout, as iron deposits impair cartilage nutrition and enhance the formation and deposition of calcium pyrophosphate dehydrate crystals. Heterozygotes for the HFE gene typically do not develop cirrhosis and remain asymptomatic due to the disorder’s low penetrance.

Understanding Pernicious Anaemia: Diagnosis and Treatment

Pernicious anaemia is a type of macrocytic anaemia caused by a deficiency of vitamin B12. This deficiency is often due to antibodies that target either intrinsic factor or the gastric parietal cells. To diagnose pernicious anaemia, blood tests for intrinsic factor antibodies and gastric parietal cell-antibodies are necessary.

Other tests, such as the PABA test, folic acid level, serum gastrin level, and C14 breath test, are not useful in identifying pernicious anaemia. Vitamin B12 is normally absorbed in the terminal ileum, but a problem in any part of this chain may result in vitamin B12 deficiency.

Patients with pernicious anaemia require lifelong vitamin B12 injections, typically six injections over the first two weeks from diagnosis and then one every three months to maintain adequate levels. Understanding the diagnosis and treatment of pernicious anaemia is crucial for managing this condition effectively.

Autoimmune Diseases: Causes and Symptoms

Autoimmune diseases are conditions where the body’s immune system attacks its own tissues and organs. Here are some examples of autoimmune diseases and their causes and symptoms:

Coeliac Disease
Coeliac disease is caused by an autoimmune reaction to gluten, a protein found in wheat. Symptoms include chronic diarrhoea, weight loss, and fatigue.

Graves’ Disease
This autoimmune disease affects the thyroid gland, resulting in hyperthyroidism. It is associated with anti-thyroid-stimulating hormone (TSH) receptor antibodies.

Pemphigus Vulgaris
This rare autoimmune disease causes blistering of the skin and mucosal surfaces due to autoantibodies against desmoglein.

Systemic Lupus Erythematosus
This multisystem autoimmune disease is associated with a wide range of autoantibodies, including anti-nuclear antibody (ANA) and anti-double-stranded (ds) DNA. Symptoms can include joint pain, fatigue, and skin rashes.

Type 1 Diabetes Mellitus
This autoimmune disease results in the destruction of islet cells in the pancreas. Islet cell autoantibodies and antibodies to insulin have been described as causes. Symptoms include increased thirst and urination, weight loss, and fatigue.

In summary, autoimmune diseases can affect various organs and tissues in the body, and their symptoms can range from mild to severe. Understanding their causes and symptoms is crucial for early diagnosis and effective treatment.

Extraintestinal Clinical Features Associated with IBD

Inflammatory bowel disease (IBD) is often accompanied by joint pain and inflammation, with migratory polyarthritis and sacroiliitis being common arthritic conditions. Other extraintestinal clinical features associated with IBD include aphthous ulcers, anterior uveitis, conjunctivitis, episcleritis, pyoderma gangrenosum, erythema nodosum, erythema multiforme, finger clubbing, primary sclerosing cholangitis, and fissures. However, aortic aneurysm is not known to be associated with IBD, as it is commonly linked to Marfan syndrome, Ehlers-Danlos syndrome, and collagen-vascular diseases. While peripheral arthropathy of the hands is associated with IBD, it is typically asymmetrical and non-deforming. Deforming arthropathy of the hands is more commonly associated with psoriatic arthritis and rheumatoid arthritis. Heberden’s nodes and Bouchard’s nodes, bony distal and proximal interphalangeal joint nodes, are found in osteoarthritis and are not associated with IBD. Prostatitis, a bacterial infection of the prostate gland, is not associated with IBD and is typically caused by Chlamydia or gonorrhoeae in young, sexually active men, and Escherichia coli in older men.